Back
Blueprint Medicines Stock Price Chart
Prepare now for a ChatGPT IPO announcement
Click here to see more
Buy
70
BPMC
Blueprint Medicines
Last Price:
50.54
Seasonality Move:
6.01%
7 Day Trial
ALL ACCESS PASS
$
7
Take advantage of the biggest IPO in history
Click here to see more- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.71 | Buy |
| 20-day SMA: | 49.43 | Buy |
| 50-day SMA: | 55.66 | Sell |
| 200-day SMA: | 50.01 | Buy |
| 8-day EMA: | 49.83 | Buy |
| 20-day EMA: | 50.79 | Sell |
| 50-day EMA: | 53.3 | Sell |
| 200-day EMA: | 53.91 | Sell |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.52 | Sell |
| Relative Strength Index (14 RSI): | 46.5 | Sell |
| Chaikin Money Flow: | 286071 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.54 - 55.36) | Sell |
| Bollinger Bands (100): | (49.68 - 60.52) | Sell |
Blueprint Medicines Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 50.64 while BPMC 8-day simple moving average is 49.71, which is a Buy signal.
- The stock price of BPMC is 50.64 while Blueprint Medicines 20-day SMA is 49.43, which makes it a Buy.
- Blueprint Medicines 50-day simple moving average is 55.66 while BPMC share price is 50.64, making it a Sell technically.
- BPMC stock price is 50.64 and Blueprint Medicines 200-day simple moving average is 50.01, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Buy
70
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a Buy
The current Blueprint Medicines [BPMC] share price is $50.64. The Score for BPMC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Blueprint Medicines Stock Info
Market Cap:
3.07B
Price in USD:
50.64
Share Volume:
553.88K
Blueprint Medicines 52-Week Range
52-Week High:
79.40
52-Week Low:
37.82
Buy
70
Blueprint Medicines (BPMC)
is a Buy
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?
The Blueprint Medicines stock price is 50.64 USD today. -
Will BPMC stock go up or go down?
Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators -
Is Blueprint Medicines overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is not overvalued.
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 50.64 while BPMC 8-day exponential moving average is 49.83, which is a Buy signal.
- The stock price of BPMC is 50.64 while Blueprint Medicines 20-day EMA is 50.79, which makes it a Sell.
- Blueprint Medicines 50-day exponential moving average is 53.30 while BPMC share price is 50.64, making it a Sell technically.
- BPMC stock price is 50.64 and Blueprint Medicines 200-day simple moving average is 53.91, creating a Sell signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.33 per share, an increase this year of $0.21 per share, and an increase next year of $1.59 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
- BPMC Moving Average Covergence Divergence (MACD) indicator is -1.52, suggesting Blueprint Medicines is a Sell
- Blueprint Medicines Relative Strength Index (RSI) is 46.5, which suggest Blueprint Medicines is oversold
- The Bollinger Bands (25) for Blueprint Medicines is (46.54 - 55.36), which suggest Blueprint Medicines is a Sell
- The Bollinger Bands (100) for Blueprint Medicines is (49.68 - 60.52), which suggest Blueprint Medicines is a Sell
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.